about
Adoptive immunotherapy against ovarian cancerComparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel.Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment.Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer.Advances in ovarian cancer therapy.Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.IL-36α suppresses proliferation of ovarian cancer cells.
P2860
Q26748905-93445A07-4C4C-45B5-8943-3340F2D6350CQ36696710-F9941B99-3CC2-4326-8D27-455F0B93798EQ38741294-4DCFF6AE-6F9B-448B-8922-9AAE34DD37A1Q42373486-DC8CC1B2-D9C3-4F09-99C8-DC81BA9AE3B6Q48104995-EB004582-9713-4956-B1C4-E8A2DC1F0571Q48192591-81D3B47D-A6D1-448A-B960-0EE41AEE9253Q50941305-D15BA4C2-B6C2-4146-ABAD-06D79206FA5C
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Immunotherapy for ovarian cancer.
@ast
Immunotherapy for ovarian cancer.
@en
type
label
Immunotherapy for ovarian cancer.
@ast
Immunotherapy for ovarian cancer.
@en
prefLabel
Immunotherapy for ovarian cancer.
@ast
Immunotherapy for ovarian cancer.
@en
P2093
P2860
P1476
Immunotherapy for ovarian cancer
@en
P2093
Alvaro S Padron
Justin M Drerup
Kruthi Murthy
Tyler J Curiel
P2860
P2888
P356
10.1007/S11864-014-0317-1
P577
2015-01-01T00:00:00Z